Newswise — Rockville, MD and New Orleans, LA—The Association of Community Cancer Centers (ACCC) announced today that Ochsner Cancer Institute in New Orleans, La., is a recipient of a 2022 ACCC Innovator Award. The award recognizes Ochsner Cancer Institute’s Chemotherapy Care Companion program—a digital technology system that allows the cancer care team to remotely monitor patients who are on intravenous or oral anti-cancer treatment to manage any symptoms or adverse events between their medical appointments.
By using their smart device, patients complete a form on their online patient portal app to enroll in the program and are then provided free of charge an iHealth digital scale, blood pressure cuff, and ear thermometer. Twice daily, patients are required to report their weight, temperature, blood pressure, heart rate, and any symptoms they may be experiencing and to complete a questionnaire.
Any abnormal vitals or questionnaire responses trigger a review by a hematology oncology advanced practice provider, and the Ochsner team intervenes as needed to provide patients high-quality cancer care support. With this technology, Ochsner Cancer Institute is keeping patients out of the emergency department or from being hospitalized and improving overall patient satisfaction. “I think this is a worthwhile program,” said Zoe Larned, MD, system chair of Hematology and Oncology at Ochsner Cancer Institute. “And the expectation among all cancer programs should be to provide this kind of remote monitoring for our patients.”
Larned will speak at the ACCC 39th National Oncology Conference about the successes and challenges she and her team experienced when developing and implementing Chemotherapy Care Companion, including the growth seen across the Ochsner Health system. Learn more about this program on the ACCCBuzz blog and CANCER BUZZ podcast, then register to attend the ACCC National Oncology Conference this October 12-14 in West Palm Beach, Fla.
About the ACCC Innovator Awards
The ACCC Innovator Awards spotlight forward-thinking ACCC Member Programs that have developed and implemented creative and cost-effective solutions to deliver patient-centered care. ACCC has recognized five winners this year, including Ochsner Health, Ochsner Cancer Institute, who are solving problems ranging from oral oncolytic tracking and improving treatment adherence to expansion of the multidisciplinary cancer care team to include primary care providers.
ACCC Innovator Award winners demonstrate the ability to advance the goals of improving access, quality, and value in cancer care delivery, while also providing replicable solutions for other cancer programs and practices.
About Ochsner Health
Ochsner Health is an integrated healthcare system with a mission to Serve, Heal, Lead, Educate and Innovate. Celebrating 80 years in 2022, it leads nationally in cancer care, cardiology, neurosciences, liver and heart transplants and pediatrics, among other areas. Ochsner is consistently named both the top hospital and top children’s hospital in Louisiana by U.S. News & World Report. The not-for-profit organization is inspiring healthier lives and stronger communities. Its focus is on preventing diseases and providing patient-centered care that is accessible, affordable, convenient and effective. Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including over 700 clinical studies. It has more than 34,000 employees and over 4,500 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 40 hospitals and more than 300 health and urgent care centers across Louisiana, Mississippi and the Gulf South; and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls. In 2021, Ochsner Health treated more than 1 million people from every state and 75 countries. As Louisiana’s top healthcare educator, Ochsner Health and its partners educate thousands of healthcare professionals annually. To learn more, visit https://www.ochsner.org/.